Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
第一作者:
Yolanda,Piña
第一单位:
Bascom Palmer Eye Institute, Miami, Florida 33101, USA.
作者:
医学主题词
动物(Animals);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);糖酵解(Glycolysis);小鼠(Mice);肿瘤, 实验性(Neoplasms, Experimental);放射性药物(Radiopharmaceuticals);视网膜肿瘤(Retinal Neoplasms);视网膜母细胞瘤(Retinoblastoma);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden)
DOI
10.1167/iovs.11-8265
PMID
22266512
发布时间
2021-10-21
基金项目
P30 EY014801/EY/NEI NIH HHS/United States
R01 EY012651/EY/NEI NIH HHS/United States
R01 EY013629/EY/NEI NIH HHS/United States
R01 EY12651/EY/NEI NIH HHS/United States
- 浏览66
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



